Five-year review of corticosteroid duration and complications in the management of immune checkpoint inhibitor-related diarrhoea and colitis in advanced melanoma

BACKGROUND: Immune-related diarrhoea/colitis (ir-D/C) is a common adverse event of immune checkpoint inhibitor (ICI) therapy. Guidelines recommend corticosteroid (CS) treatment; however, the average treatment duration for ir-D/C remains poorly defined. METHODS: All advanced melanoma patients treated...

Full description

Saved in:
Bibliographic Details
Published in:ESMO Open
Main Authors: Favara, David M, Spain, Lavinia, Au, Lewis, Clark, James, Daniels, Ella, Diem, Stefan, Chauhan, Dharmisha, Turajlic, Samra, Powell, Nick, Larkin, James M, Yousaf, Nadia
Format: Artigo
Language:Inglês
Published: BMJ Publishing Group 2020
Subjects:
Original Research
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC7348326/
https://ncbi.nlm.nih.gov/pubmed/32641348
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/esmoopen-2019-000585
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items